Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Conditions
Diabetic Foot Ulcers
Interventions
DEVICE

KLOX BioPhotonic System

KLOX BioPhotonic System (Multi-LED Light and KLOX Photo Converter Wound Gel) will be administered until wound closure or for a maximum of 24 weeks, followed by a 8-week follow-up period, in association with Standard Of Care for diabetic foot ulcers.

Trial Locations (3)

G7H 7Y8

Q&T Research Chicoutimi, Chicoutimi

H7T 2P5

Centre de Recherche Clinique de Laval, Laval

H3Z 1C3

Victoria Park MediSpa, Westmount

Sponsors
All Listed Sponsors
lead

KLOX Technologies Inc.

INDUSTRY